FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082922862> ?p ?o ?g. }

• W3082922862 abstract "Breast cancer is a group of diseases in which cells divide out of controlled, typically resulting in a mass. Erlotinib is targeted cancer drug which functions as an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used mainly to treat of non-small cell lung cancer patients and has an action against pancreatic cancer. Vorinostat (aka suberanilohydroxamic acid) is an inhibitor of histone deacetylases (HDAC), which has an epigenetic modulation activity. It is used to treat cutaneous T cell lymphoma. In the present study, the erlotinib (ERL) and vorinostat (SAHA) loaded TiO2 nanoparticles (NPs) were used for the treatment of the breast cancer cells (MDA-MB-231 and MCF-7) and human cancerous amniotic cells (WISH). Cell count and viability were negatively affected in all treatments compared to normal cells and bare TiO2 NPs. Apoptosis results indicated a significant increase in the total apoptosis in all treatments compared with control cells. ERL- and SAHA-loaded TiO2 NPs treatments arrested breast cancer cells at G2/M phase, which indicate the cytotoxic effect of these treatment. Partner and localizer of BRCA2 (PALB2) gene expression was assessed using qPCR. The results indicate that PLAB2 was upregulated in ERL- and SAHA-loaded TiO2 NPs compared with control cells and can be used as nanocarrier for chemotherapy drugs. However, this conclusion necessitates further confirmative investigation." @default.
• W3082922862 created "2020-09-08" @default.
• W3082922862 creator A5025286616 @default.
• W3082922862 creator A5027436691 @default.
• W3082922862 creator A5038496397 @default.
• W3082922862 creator A5048402911 @default.
• W3082922862 creator A5058476066 @default.
• W3082922862 creator A5064819189 @default.
• W3082922862 creator A5065033451 @default.
• W3082922862 creator A5065874897 @default.
• W3082922862 creator A5066591868 @default.
• W3082922862 creator A5081604063 @default.
• W3082922862 creator A5089173040 @default.
• W3082922862 date "2020-08-27" @default.
• W3082922862 modified "2023-10-10" @default.
• W3082922862 title "Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation" @default.
• W3082922862 cites W1710716389 @default.
• W3082922862 cites W1919860420 @default.
• W3082922862 cites W1974167857 @default.
• W3082922862 cites W1977621019 @default.
• W3082922862 cites W1990540805 @default.
• W3082922862 cites W1991605561 @default.
• W3082922862 cites W2005433498 @default.
• W3082922862 cites W2014449605 @default.
• W3082922862 cites W2030510435 @default.
• W3082922862 cites W2034133622 @default.
• W3082922862 cites W2039759758 @default.
• W3082922862 cites W2048835427 @default.
• W3082922862 cites W2101610367 @default.
• W3082922862 cites W2108578850 @default.
• W3082922862 cites W2109197874 @default.
• W3082922862 cites W2144864194 @default.
• W3082922862 cites W2181968133 @default.
• W3082922862 cites W2321371720 @default.
• W3082922862 cites W2415409185 @default.
• W3082922862 cites W2418502108 @default.
• W3082922862 cites W2536907894 @default.
• W3082922862 cites W2547782348 @default.
• W3082922862 cites W2552327471 @default.
• W3082922862 cites W2553091174 @default.
• W3082922862 cites W2578126608 @default.
• W3082922862 cites W2601819349 @default.
• W3082922862 cites W2616289499 @default.
• W3082922862 cites W2735766035 @default.
• W3082922862 cites W2741600854 @default.
• W3082922862 cites W2753008793 @default.
• W3082922862 cites W2769988599 @default.
• W3082922862 cites W2806893772 @default.
• W3082922862 cites W2811313862 @default.
• W3082922862 cites W2889725027 @default.
• W3082922862 cites W2899092577 @default.
• W3082922862 cites W2901416351 @default.
• W3082922862 cites W2906541310 @default.
• W3082922862 cites W2907893876 @default.
• W3082922862 cites W2913808284 @default.
• W3082922862 cites W2924471007 @default.
• W3082922862 cites W2930954504 @default.
• W3082922862 cites W2938054231 @default.
• W3082922862 cites W2976536295 @default.
• W3082922862 cites W2985884536 @default.
• W3082922862 cites W2991285002 @default.
• W3082922862 cites W3002656882 @default.
• W3082922862 cites W3006905885 @default.
• W3082922862 cites W3031322238 @default.
• W3082922862 doi "https://doi.org/10.1007/s13205-020-02391-2" @default.
• W3082922862 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7452998" @default.
• W3082922862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32904337" @default.
• W3082922862 hasPublicationYear "2020" @default.
• W3082922862 type Work @default.
• W3082922862 sameAs 3082922862 @default.
• W3082922862 citedByCount "16" @default.
• W3082922862 countsByYear W30829228622020 @default.
• W3082922862 countsByYear W30829228622021 @default.
• W3082922862 countsByYear W30829228622022 @default.
• W3082922862 countsByYear W30829228622023 @default.
• W3082922862 crossrefType "journal-article" @default.
• W3082922862 hasAuthorship W3082922862A5025286616 @default.
• W3082922862 hasAuthorship W3082922862A5027436691 @default.
• W3082922862 hasAuthorship W3082922862A5038496397 @default.
• W3082922862 hasAuthorship W3082922862A5048402911 @default.
• W3082922862 hasAuthorship W3082922862A5058476066 @default.
• W3082922862 hasAuthorship W3082922862A5064819189 @default.
• W3082922862 hasAuthorship W3082922862A5065033451 @default.
• W3082922862 hasAuthorship W3082922862A5065874897 @default.
• W3082922862 hasAuthorship W3082922862A5066591868 @default.
• W3082922862 hasAuthorship W3082922862A5081604063 @default.
• W3082922862 hasAuthorship W3082922862A5089173040 @default.
• W3082922862 hasBestOaLocation W30829228622 @default.
• W3082922862 hasConcept C104317684 @default.
• W3082922862 hasConcept C121608353 @default.
• W3082922862 hasConcept C126322002 @default.
• W3082922862 hasConcept C185592680 @default.
• W3082922862 hasConcept C190283241 @default.
• W3082922862 hasConcept C2776202225 @default.
• W3082922862 hasConcept C2776262904 @default.
• W3082922862 hasConcept C2778087573 @default.
• W3082922862 hasConcept C2778305200 @default.
• W3082922862 hasConcept C2779438470 @default.
• W3082922862 hasConcept C2780210213 @default.
• W3082922862 hasConcept C502942594 @default.

• next